Soligenix expands European medical advisory board for lymphoma treatment
PositiveFinancial Markets

Soligenix has expanded its European medical advisory board to enhance its efforts in developing treatments for lymphoma. This move is significant as it brings together a team of experts who can provide valuable insights and guidance, potentially accelerating the development of innovative therapies. With lymphoma being a challenging condition to treat, this expansion could lead to improved outcomes for patients in Europe and beyond.
— Curated by the World Pulse Now AI Editorial System